论文部分内容阅读
目的探讨对肝转移瘤以拓僖联合超液化碘油进行化疗栓塞(TACE)治疗的安全性与有效性。方法对28例肝转移瘤患者以拓僖为主的化疗药物联合超液化碘油进行化疗栓塞(TA-CE)治疗,评价其临床疗效及毒副反应。结果经拓僖为主的化疗药物联合超液化碘油进行TACE治疗后,总有效率78.6%(22/28)。主要不良反应是骨髓抑制及肝功能损害,以Ⅰ、Ⅱ度为主,其次是发热、恶心呕吐及腹泻。结论以拓僖为主的化疗药物联合超液化碘油进行化疗栓塞(TACE)治疗肝转移瘤是一种安全有效的方法,其不良反应可耐受。
Objective To investigate the safety and efficacy of hepatic metastasis tumors combined with tiotropin combined with lipiodol for chemoembolization (TACE). Methods Twenty-eight patients with hepatic metastases were treated with chemotherapy based on thioglycollium-based chemotherapy combined with lipiodol (TA-CE) to evaluate their clinical efficacy and side effects. Results After the TACE treatment with the combination of chemotherapeutic drugs based on tantalum and lipiodol, the total effective rate was 78.6% (22/28). The main adverse reactions were myelosuppression and hepatic impairment, with degrees I, II, followed by fever, nausea, vomiting, and diarrhea. Conclusion The treatment of hepatic metastasis by chemotherapy with Tembolide, a chemotherapy drug based on Tuobu, combined with lipiodol, is a safe and effective method. The adverse reactions can be tolerated.